|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prepaid expenses | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets: | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Total accounts payable and accrued expenses | ||||||||||||||||||||
| Accounts payable - related party | ||||||||||||||||||||
| Loans from related parties | ||||||||||||||||||||
| Convertible note payable | ||||||||||||||||||||
| Convertible notes payable - related party, net | ||||||||||||||||||||
| Short-term convertible notes payable, net | ||||||||||||||||||||
| Convertible notes payable, default | ||||||||||||||||||||
| Short-term notes payable, net | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Total derivative liability | ||||||||||||||||||||
| Court judgment liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term convertible notes payable, net | ||||||||||||||||||||
| Long-term convertible notes payable, related party, net | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series D Convertible Preferred | ||||||||||||||||||||
| Series F Convertible Preferred | ||||||||||||||||||||
| Series E Convertible Preferred | ||||||||||||||||||||
| Series D Convertible Preferred Stock | ||||||||||||||||||||
| Series E convertible Preferred Stock | ||||||||||||||||||||
| Series E Convertible Preferred Stock | ||||||||||||||||||||
| Series F Convertible Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Common stock, $0.00001 par value. 6.5 billion shares authorized. 6,237,077,061 and 5,866,608,915 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Common stock payable | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Effect of foreign currency exchange | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| TOTAL STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
Loading...
